Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial

Botulinum toxin A is considered an important tool to control spasticity in children with cerebral palsy. Several factors are known to affect the efficacy of botulinum toxin, such as dosage, appropriate muscle selection and application, age, and accompanying therapy. A multicenter, double-blind, rand...

Full description

Bibliographic Details
Main Authors: Bo Young Hong, Hyun Jung Chang, Sang-Jee Lee, Soyoung Lee, Joo Hyun Park, Jeong-Yi Kwon
Format: Article
Language:English
Published: MDPI AG 2017-08-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/9/8/253
_version_ 1811186094909161472
author Bo Young Hong
Hyun Jung Chang
Sang-Jee Lee
Soyoung Lee
Joo Hyun Park
Jeong-Yi Kwon
author_facet Bo Young Hong
Hyun Jung Chang
Sang-Jee Lee
Soyoung Lee
Joo Hyun Park
Jeong-Yi Kwon
author_sort Bo Young Hong
collection DOAJ
description Botulinum toxin A is considered an important tool to control spasticity in children with cerebral palsy. Several factors are known to affect the efficacy of botulinum toxin, such as dosage, appropriate muscle selection and application, age, and accompanying therapy. A multicenter, double-blind, randomized, prospective phase III clinical trial of botulinum toxin A for the treatment of dynamic equinus in 144 children with cerebral palsy was performed to compare the efficacies of letibotulinumtoxin A and onabotulinumtoxin A. Secondary analyses were performed to evaluate factors that affected the outcome, focusing on the number of times injections were repeated. Effectiveness was defined as a change of 2 or more in the physician’s rating scale. Multivariate regression analyses were performed with multiple variables. The first injection of botulinum toxin A significantly improved D subscale of Gross Motor Function Measure-88 scores at 3 months compared to repeated injections (p < 0.05). After 6 months, patients who had one injection or none before the study showed significantly better outcomes than those who had more than one injection in terms of observational gait scores.
first_indexed 2024-04-11T13:39:55Z
format Article
id doaj.art-7edcdc9d83874373b0d5a5295f219bf5
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T13:39:55Z
publishDate 2017-08-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-7edcdc9d83874373b0d5a5295f219bf52022-12-22T04:21:17ZengMDPI AGToxins2072-66512017-08-019825310.3390/toxins9080253toxins9080253Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical TrialBo Young Hong0Hyun Jung Chang1Sang-Jee Lee2Soyoung Lee3Joo Hyun Park4Jeong-Yi Kwon5Department of Rehabilitation Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon 16247, South KoreaDepartment of Physical Medicine & Rehabilitation, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, South KoreaDepartment of Rehabilitation Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon 34943, South KoreaDepartment of Physical Medicine & Rehabilitation, Keimyung University, Dongsan Medical Center, Daegu 41931, South KoreaDepartment of Rehabilitation Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, South KoreaDepartment of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South KoreaBotulinum toxin A is considered an important tool to control spasticity in children with cerebral palsy. Several factors are known to affect the efficacy of botulinum toxin, such as dosage, appropriate muscle selection and application, age, and accompanying therapy. A multicenter, double-blind, randomized, prospective phase III clinical trial of botulinum toxin A for the treatment of dynamic equinus in 144 children with cerebral palsy was performed to compare the efficacies of letibotulinumtoxin A and onabotulinumtoxin A. Secondary analyses were performed to evaluate factors that affected the outcome, focusing on the number of times injections were repeated. Effectiveness was defined as a change of 2 or more in the physician’s rating scale. Multivariate regression analyses were performed with multiple variables. The first injection of botulinum toxin A significantly improved D subscale of Gross Motor Function Measure-88 scores at 3 months compared to repeated injections (p < 0.05). After 6 months, patients who had one injection or none before the study showed significantly better outcomes than those who had more than one injection in terms of observational gait scores.https://www.mdpi.com/2072-6651/9/8/253cerebral palsyspasticitybotulinum toxinonabotulinumtoxin Aletibotulinumtoxin Aequinus
spellingShingle Bo Young Hong
Hyun Jung Chang
Sang-Jee Lee
Soyoung Lee
Joo Hyun Park
Jeong-Yi Kwon
Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
Toxins
cerebral palsy
spasticity
botulinum toxin
onabotulinumtoxin A
letibotulinumtoxin A
equinus
title Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
title_full Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
title_fullStr Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
title_full_unstemmed Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
title_short Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy—A Secondary Analysis of the Randomized Clinical Trial
title_sort efficacy of repeated botulinum toxin type a injections for spastic equinus in children with cerebral palsy a secondary analysis of the randomized clinical trial
topic cerebral palsy
spasticity
botulinum toxin
onabotulinumtoxin A
letibotulinumtoxin A
equinus
url https://www.mdpi.com/2072-6651/9/8/253
work_keys_str_mv AT boyounghong efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial
AT hyunjungchang efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial
AT sangjeelee efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial
AT soyounglee efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial
AT joohyunpark efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial
AT jeongyikwon efficacyofrepeatedbotulinumtoxintypeainjectionsforspasticequinusinchildrenwithcerebralpalsyasecondaryanalysisoftherandomizedclinicaltrial